La cadena de opciones muestra datos clave de las opciones de acciones de OSR Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para OSR Holdings..

OSR Holdings (NASDAQ:OSRH) Bolsa, Cadena de Opciones

OSR Holdings

OSR Holdings Inc is a healthcare company, dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of and potentially transformative therapies and healthcare solutions.

OSR Holdings Inc

Stifel analyst Benjamin Burnett maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and lowers the price target from $78 to $64.

News

Price Target

Analyst Ratings

RVMD

Stifel Maintains Buy on Revolution Medicines, Lowers Price Target to $64

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) with a Buy and raises the price target from $19 to $25.

CLPT

Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

Loop Capital analyst Alton Stump upgrades Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) from Hold to Buy and announces $127 price target.

Upgrades

SHAK

Loop Capital Upgrades Shake Shack to Buy, Announces $127 Price Target

Piper Sandler analyst Paul Newsome maintains The Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) with a Overweight and raises the price target from $190 to $205.

Piper Sandler Maintains Overweight on The Hanover Insurance Gr, Raises Price Target to $205

President Donald Trump has set up a new body within the Commerce Department to manage the CHIPS and Science Act, 2022. 
What Happened: A new entity, the United States Investment Accelerator within the Commerce Department, will now oversee the CHIPS Act program, as established by an executive order signed by Trump on Monday.
Despite Trump&#8217;s past criticism of the bipartisan legislation, the White House said in its fact sheet that the new office will focus on &#8220;negotiating much better CHIPS Act deals&#8221; and streamlining investment processes through reduced regulatory burdens and faster permitting.
According to the <a href="https://www.semiconductors.org/chip-supply-chain-investments/">Semiconductor Industry Association</a>, the CHIPS Program has granted awards worth $32.5417 billion and provided loans up to $5.85 billion to 32 companies across 23 states. 
However, the new entity — Investment Accelerator that will be controlling the CHIPS Act, not only plans to expedite corporate investments but promises to deliver &#8221; the benefit of the bargain for taxpayers,&#8221; as per the Whit House fact sheet.
Other primary goals of the body include;
<ul>
<li>Reducing regulatory burdens</li>
</ul>
<ul>
<li>Speeding up permitting;</li>
</ul>
<ul>
<li>Coordinating responses to investor issues across multiple Federal agencies; </li>
</ul>
<ul>
<li>Increasing access to national resources;</li>
</ul>
<ul>
<li>Facilitating collaboration with national laboratories; </li>
</ul>
<ul>
<li>Working with all 50 state governments and their economic development organizations.</li>
</ul>
Here are the U.S.-listed beneficiaries that have received grants under the CHIPS and Science Act, 2022 in the past. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Company Stocks</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>Amkor Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>)</td>
<td>-30.57%</td>
<td>-43.23%</td>
</tr>
<tr>
<td>Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>)</td>
<td>-4.58%</td>
<td>2.57%</td>
</tr>
<tr>
<td>Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>)</td>
<td>-35.44%</td>
<td>8.23%</td>
</tr>
<tr>
<td>Corning Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>)</td>
<td>-1.99%</td>
<td>40.13%</td>
</tr>
<tr>
<td>Entegris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>)</td>
<td>-10.03%</td>
<td>-37.79%</td>
</tr>
<tr>
<td>Globalfoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>)</td>
<td>-13.11%</td>
<td>-28.73%</td>
</tr>
<tr>
<td>HP Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>)</td>
<td>-14.72%</td>
<td>-8.85%</td>
</tr>
<tr>
<td>Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)</td>
<td>12.31%</td>
<td>48.99%</td>
</tr>
<tr>
<td>MACOM Technology Solutions Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>)</td>
<td>-22.44%</td>
<td>2.83%</td>
</tr>
<tr>
<td>Microchip Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</td>
<td>-14.89%</td>
<td>-46.06%</td>
</tr>
<tr>
<td>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>)</td>
<td>-0.50%</td>
<td>-30.10%</td>
</tr>
<tr>
<td>Polar Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>)</td>
<td>-30.66%</td>
<td>-31.05%</td>
</tr>
<tr>
<td>Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)</td>
<td>-28.37%</td>
<td>338%</td>
</tr>
<tr>
<td>Skywater Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>)</td>
<td>-47.36%</td>
<td>-30.08%</td>
</tr>
<tr>
<td>Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</td>
<td>-3.88%</td>
<td>3.77%</td>
</tr>
<tr>
<td>Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)</td>
<td>-17.65%</td>
<td>17.32%</td>
</tr>
<tr>
<td>Wolfspeed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>)</td>
<td>-53.85%</td>
<td>-89.77%</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/04/44578555/nancy-pelosis-pick-palo-alto-networks-downplays-ai-spending-need-analyst-warns-ai-digestion-phase-may-be-a-larger-problem" target="_blank" rel="noreferrer noopener">Nancy Pelosi's Pick, Palo Alto Networks Downplays AI Spending Need: Analyst Warns ‘AI Digestion Phase May Be A Larger Problem'</a>
Why It Matters: Trump has been vocal about his criticism of the CHIPS Act. On March 4, during his joint address to Congress, he said, &#8220;Your Chips Act is a horrible, horrible thing.&#8221;
He also urged U.S. House Speaker Mike Johnson to &#8220;get rid&#8221; of it and use &#8220;whatever is left over&#8221; to &#8220;reduce debt or any other reason you want to.&#8221;
However, the White House&#8217;s new plan has passed on the management of the act to the new entity. Since his time in office, Trump has been able to convince companies to invest in the U.S.
In early March, Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE: TSM revealed its plans to inject another $100 billion into U.S. advanced semiconductor manufacturing, significantly expanding its ongoing $65 billion Arizona initiative and bringing total investment to $165 billion.
Similarly, the Magnificent 7 companies are widely expected to spend more than $330 billion on capex in 2025. While the chipmaker Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) hasn't explicitly mentioned a target during its earnings call, the iPhone maker Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) broadly expects to spend $500 billion over the next four years. The remaining companies, however, have provided a specific target for 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Stocks</td>
<td>CAPEX Target For 2025</td>
</tr>
<tr>
<td>Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>&#8211;</td>
</tr>
<tr>
<td>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)</td>
<td>&#8211;</td>
</tr>
<tr>
<td>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</td>
<td>$80 Billion</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>$100 Billion</td>
</tr>
<tr>
<td>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</td>
<td>$75 Billion</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>$65 Billion</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>$11 Billion</td>
</tr>
</tbody>
</table>
</figure>
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, dropped in premarket on Monday. The SPY was down 0.51% to $556.56, while the QQQ declined 0.46% to $466.75, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44579361/charlie-mungers-top-pick-costcos-golden-touch-gold-prices-soar-58-outpacing-spy-since-it-started-selling-gold-33-months-ago">Charlie Munger&#8217;s Top Pick Costco&#8217;s Golden Touch: Gold Prices Soar 58%, Outpacing SPY Since It Started Selling Gold 33 Months Ago</a></li>
</ul>
Image via Shutterstock

Equities

Government

Regulations

Politics

Markets

General

AAPL

AMKR

AMZN

COHR

ENTG

GOOGL

INTC

MCHP

MSFT

MTSI

NVDA

POLA

RKLB

SKYT

TSLA

WOLF

Days After Calling The CHIPS Act A 'Horrible Thing' Donald Trump Sets Up New Entity For 'Negotiating Much Better...Deals:' Here's More

ANGI

IAC Completes Spin-off Of Angi

Piper Sandler analyst Paul Newsome maintains Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) with a Overweight and raises the price target from $41 to $43.

Piper Sandler Maintains Overweight on Old Republic Intl, Raises Price Target to $43

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>)</h3>
<ul>
<li>Dividend Yield: 7.82%</li>
<li>UBS analyst Jay Sole maintained a Neutral rating and slashed the price target from $57 to $49 on Feb. 26, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Citigroup analyst Paul Lejuez maintained a Neutral rating and cut the price target from $50 to $45 on Feb. 26, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On March 26, Carter&#8217;s named Douglas C. Palladini as Chief Executive Officer.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401">CRI news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401"><img loading="lazy" decoding="async" width="910" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050408/image-6.png" alt="" class="wp-image-850727" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050408/image-6.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050408/image-6-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050408/image-6-768x695.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Whirlpool Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>)</h3>
<ul>
<li>Dividend Yield: 7.77%</li>
<li>JP Morgan analyst Michael Rehaut maintained a Neutral rating and raised the price target from $103 to $109 on Oct. 29, 2024. This analyst has an accuracy rate of 72%.</li>
<li>RBC Capital analyst Mike Dahl maintained an Underperform rating and cut the price target from $76 to $74 on Oct. 25, 2024. This analyst has an accuracy rate of 74%</li>
<li>Recent News: On Feb. 17, Whirlpool appointed John Morikis, former chairman and CEO of The Sherwin-Williams Company, to the board.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest WHR <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401"><img loading="lazy" decoding="async" width="902" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050443/image-7.png" alt="" class="wp-image-850731" style="width:511px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050443/image-7.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050443/image-7-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050443/image-7-768x701.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">Jack in the Box Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>)</h3>
<ul>
<li>Dividend Yield: 6.47%</li>
<li>Stifel analyst Chris O'Cull maintained a Hold rating and cut the price target from $40 to $35 on March 24, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Truist Securities analyst Jake Bartlett maintained a Buy rating and slashed the price target from $57 to $51 on Feb. 26, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On March 31, Jack in the Box named Lance Tucker as its Chief Executive Officer.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to la<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401">test JACK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401"><img loading="lazy" decoding="async" width="903" height="811" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050514/image-8.png" alt="" class="wp-image-850732" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050514/image-8.png 903w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050514/image-8-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01050514/image-8-768x690.png 768w" sizes="(max-width: 903px) 100vw, 903px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44561974/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Trading Ideas

JACK

Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields

Piper Sandler analyst Paul Newsome maintains The Hartford Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) with a Overweight and raises the price target from $130 to $145.

Piper Sandler Maintains Overweight on The Hartford Insurance Gr, Raises Price Target to $145

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs cut Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) price target from $133 to $114. Goldman Sachs analyst Kate McShane downgraded the stock from Neutral to Sell. Genuine Parts shares closed at $119.14 on Monday.<a href="https://www.benzinga.com/quote/GPC/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>Needham slashed the price target for Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) from $140 to $90. Needham analyst Joseph Stringer maintained a Buy rating. Vaxcyte shares closed at $37.76 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/PCVX/analyst-ratings">view this stock</a>.</li>
<li>Goldman Sachs raised Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) price target from $384 to $423. Goldman Sachs analyst Kate McShane upgraded the stock from Neutral to Buy. Ulta Beauty shares closed at $366.54 on Monday. <a href="https://www.benzinga.com/quote/ULTA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Securities increased the price target for First Watch Restaurant Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) from $21 to $22. TD Securities analyst Andrew Charles upgraded the stock from Hold to Buy. First Watch Restaurant shares closed at $16.65 on Monday. <a href="https://www.benzinga.com/quote/FWRG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. raised slashed the price target for BiomX Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#NYSE">PHGE</a>) from $2 to $21. HC Wainwright &amp; Co. analyst Joseph Pantginis maintained a Buy rating. BiomX shares closed at $0.5557 on Monday. <a href="https://www.benzinga.com/quote/PHGE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>D. Boral Capital cut Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) price target from $15 to $8. D. Boral Capital analyst Jason Kolbert maintained a Buy rating. Reviva Pharmaceuticals shares settled at $0.9538 on Monday. <a href="https://www.benzinga.com/quote/RVPH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho cut PBF Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) price target from $28 to $22. Mizuho analyst Nitin Kumar maintained an Underperform rating. PBF Energy shares closed at $19.09 on Monday. <a href="https://www.benzinga.com/quote/PBF/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised Travere Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) price target from $29 to $31. B of A Securities analyst Greg Harrison maintained a Buy rating. Travere Therapeutics shares closed at $17.92 on Monday.  <a href="https://www.benzinga.com/quote/TVTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities slashed the price target for Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from $66 to $46. B of A Securities analyst Ken Hoexter downgraded the stock from Buy to Neutral. Knight-Swift Transportation shares settled at $43.49 on Monday. <a href="https://www.benzinga.com/quote/KNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies cut Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) price target from $85 to $46. Jefferies analyst Sheila Kahyaoglu downgraded the stock from Buy to Hold. Delta Air shares closed at $43.60 on Monday. <a href="https://www.benzinga.com/quote/DAL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01084306/image-12-1024x579.png" alt="" class="wp-image-851127" style="width:621px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01084306/image-12-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01084306/image-12-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01084306/image-12-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01084306/image-12.png 1100w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Photo via Shutterstock

FWRG

PCVX

PHGE

RVPH

TVTX

ULTA

Ulta Beauty To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday

Barclays analyst Andrew Mok initiates coverage on Astrana Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTH#NASDAQ">ASTH</a>) with a Equal-Weight rating and announces Price Target of $36.

Initiation

ASTH

Barclays Initiates Coverage On Astrana Health with Equal-Weight Rating, Announces Price Target of $36

Piper Sandler analyst Paul Newsome maintains Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) with a Overweight and raises the price target from $310 to $335.

Piper Sandler Maintains Overweight on Chubb, Raises Price Target to $335

WIIM

Genuine Parts shares are trading lower after Goldman Sachs downgraded the stock from Neutral to Sell and cut its price target from $133 to $114.

Barclays analyst Steve Valiquette initiates coverage on Brookdale Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) with a Equal-Weight rating and announces Price Target of $7.

Barclays Initiates Coverage On Brookdale Senior Living with Equal-Weight Rating, Announces Price Target of $7

Barclays analyst Jared Shaw initiates coverage on SouthState (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) with a Overweight rating and announces Price Target of $120.

Barclays Initiates Coverage On SouthState with Overweight Rating, Announces Price Target of $120

Ed Yardeni, the veteran Wall Street strategist known for his bullish &#8216;Roaring 2020s&#8217; thesis, is dialing back optimism and raising stagflation alarms as a new wave of U.S. tariffs threatens to throttle corporate margins <a href="https://www.benzinga.com/topic/inflation">and push inflation higher.</a>
In his latest Yardeni&#8217;s quicktake, the analyst reduced the odds of his Roaring 2020s scenario for the decade from 65% to 55%, while raising the probability of a stagflationary outcome—defined as slowing growth coupled with elevated inflation—to 45%.
That shift, Yardeni said, stems from President Donald Trump's newly announced 25% tariff on imported autos and parts, effective April 3, adding to the burden of earlier tariffs on steel and aluminum. 
The latest tariff salvo—soon to be followed by a likely 20% blanket duty on all imported goods—is expected to raise input costs for businesses across sectors, with consumers likely to face rising prices. 
Read also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44458099/us-economy-faces-fork-in-the-road-is-yardenis-roaring-2020s-still-possible">US Economy Faces &#8216;Fork In The Road&#8217;: Is Yardeni&#8217;s &#8216;Roaring 2020s&#8217; Still Possible?</a>
<h3 class="wp-block-heading">How Tariffs Are Fueling Inflation Fears</h3>
Yardeni now sees the 2025 inflation rate, measured by the Personal Consumption Expenditures Deflator – the Federal Reserve's preferred inflation gauge – rising to 3.0%-4.0%, up from the prior 2.0%-3.0% estimate.
While supercore inflation—which strips out volatile components like housing—has been trending lower, that progress may stall, according to the expert. 
Durable goods prices, which had been in deflation, are now expected to rise again in the second quarter, while nondurable goods inflation could top 1.5% year-over-year.
"The end of goods deflation combined with sticky and too-high services inflation risk sending inflation expectations—and therefore actual inflation—climbing out of control," Yardeni said.
&#8220;A happy outcome would be that the U.S. would negotiate tariff reductions, but that won&#8217;t happen if the U.S. slaps a 20% tariff on all imports across-the-board just because Peter Navarro has convinced the President that tariffs will bring $6 trillion in revenue over the next 10 years,&#8221; he added.
<h3 class="wp-block-heading">Profit Margins Under Pressure</h3>
While revenue expectations remain unchanged for now, Yardeni said he's trimming his 2025 and 2026 earnings forecasts for the S&amp;P 500 index. 
This year's earnings per share estimate was cut from $275 to $260, and the 2026 projection was lowered from $320 to $300, reflecting &#8220;squeezed profit margins&#8221; from rising costs.
Yardeni's S&amp;P 500 price targets have adjusted accordingly. He now expects the index to land between 5100 and 6000 by year-end, with a modest move higher to 5950–7000 in 2026. 
The S&amp;P 500 index – as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – ended the first quarter of the year with a contraction of 4.6%, notching the worst quarterly performance since mid-2022. 
<h3 class="wp-block-heading">Will The Fed Move? Yardeni Says No</h3>
The Federal Reserve's next steps remain a wild card. Tariffs add complexity to an already delicate balancing act: fighting inflation without crippling growth. 
Some observers fear that unanchored inflation expectations—when households and firms begin acting as if inflation will stay high—could create a self-fulfilling feedback loop.
Yardeni, however, doesn't see the Fed reacting aggressively. He's sticking with a "none-and-done" view for 2025—meaning no further rate cuts. That contrasts with growing market chatter about a potential pivot in response to slowing growth.
Currently, market-based interest rate forecasts – as tracked by the CME FedWatch Tool – are fully pricing in three rate cuts by year end.
&#8220;Inflation expectations is likely to be one of the Federal Reserve's phrases of the year,&#8221; Yardeni said, noting that people's expectations about future inflation are critical to how high inflation actually climbs.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44572838/treasury-bonds-have-lost-50-in-5-years-yet-reversal-signals-emerge-in-q1-could-tariffs-actually-push-tlt-higher">Treasury Bonds Have Lost 50% In 5 Years, Yet Reversal Signals Emerge In Q1: Could Tariffs Actually Push TLT Higher?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

Veteran Investor Warns Of Rising Stagflation Risk As Tariffs Loom, Anticipates 'Squeezed Profit Margins' For US Businesses

GIPR

Generation Income Properties shares are trading lower. The company reported FY24 financial results.

Earnings

LQR House GGY24 Revenue $2.501M Up From $1.120M YoY

Guidance

Generation Income Properties FY24 EPS ($1.64) Up From ($2.46) YoY; Revenue $9.51M Up From $7.59M YoY

Barclays analyst Jared Shaw initiates coverage on Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) with a Equal-Weight rating and announces Price Target of $130.

Barclays Initiates Coverage On Cullen/Frost Bankers with Equal-Weight Rating, Announces Price Target of $130

Press Releases

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment

Comments

OSR Holdings

OSR Holdings (OSRH) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL